"Enterprise Therapeutics Secures £26M Funding Boost for Continued Growth" | FunderLyst

TLDR:

Brighton-based biopharmaceutical company Enterprise Therapeutics has raised £26m in a series B follow-on funding round.
The financing round was led by Panakes Partners and saw participation from existing investors Versant Ventures, Novartis Venture Fund, Forbion, Epidarex Capital and IP Group.
The funds will be used to accelerate the Phase 2a clinical trial of Enterprise Therapeutics’ lead program, ETD001, to develop treatments for cystic fibrosis and expand clinical activities in Italy.

Brighton-based biopharmaceutical company Enterprise Therapeutics has secured £26m in series B follow-on funding. The round was led by Panakes Partners, with participation from existing investors Versant Ventures, Novartis Venture Fund, Forbion, Epidarex Capital and IP Group. The funds will be used to accelerate the Phase 2a clinical trial of Enterprise Therapeutics’ lead program, ETD001, which aims to develop treatments for cystic fibrosis. The clinical trial will test the effectiveness of ETD001 in improving lung function in patients with cystic fibrosis who are either ineligible for or not receiving CFTR modulators.

Post Views: 70

Adrian Johnson

Latest from Blog

Arch Venture Partners secures over $3bn for Fund XIII

TLDR: Arch Venture Partners has raised over $3 billion for Fund XIII. Investors in the fund include Alaska Permanent Fund and Rockefeller Brothers Fund. In a recent development, Arch Venture Partners has

Raising Your First Venture Fund: Tips for Success

TLDR: Samir Kaji, a seasoned venture capital professional, shares a six-point plan for raising a venture fund as a first-time fund manager. Key steps include staying focused on a niche, not worrying

Exploring China’s Quantum Computing Breakthrough and VC Trends

TLDR: ONCO stock surged over 80% in pre-market after Altos Venture acquired a stake Chinese low float stocks like DUO rose over 40% in sympathy with large caps Summary: The article discusses

The Blindspot: Venture Capitalists’ Go-To Tool with Fatal Flaw

TLDR: Nader Al-Naji, founder of Bitclout, was arrested for an alleged crypto scam involving VC giant Andreessen Horowitz as a victim. VCs’ pattern matching led them to invest in Al-Naji despite red

Korean startups seek corporate investors in challenging ecosystem climate

TLDR: Korean startups are seeking corporate investors as funding becomes harder to secure. The government in South Korea has relaxed CVC rules to attract more foreign investment. Korean startups are facing a

Go toTop

Seraphinite Accelerator

Optimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.